32 results on '"Bot A"'
Search Results
2. An acoustic signature of extreme failure on model granular materials
- Author
-
Nguyên, T. T. T., Doanh, T., Bot, A. Le, and Dalmas, D.
- Published
- 2022
- Full Text
- View/download PDF
3. Blockade of the BLT1-LTB4 axis does not affect mast cell migration towards advanced atherosclerotic lesions in LDLr−/− mice
- Author
-
Depuydt, Marie A. C., Vlaswinkel, Femke D., Hemme, Esmeralda, Delfos, Lucie, Kleijn, Mireia N. A. Bernabé, van Santbrink, Peter J., Foks, Amanda C., Slütter, Bram, Kuiper, Johan, and Bot, Ilze
- Published
- 2022
- Full Text
- View/download PDF
4. Publisher Correction: High-temporal-resolution quasideterministic dynamics of granular stick-slip
- Author
-
Nguyen, T. T. T., Doanh, T., Le Bot, A., and Dalmas, D.
- Published
- 2021
- Full Text
- View/download PDF
5. High-temporal-resolution quasideterministic dynamics of granular stick-slip
- Author
-
Nguyen, T. T. T., Doanh, T., Le Bot, A., and Dalmas, D.
- Published
- 2021
- Full Text
- View/download PDF
6. A cell-based bioluminescence assay reveals dose-dependent and contextual repression of AP-1-driven gene expression by BACH2
- Author
-
Vardaka, Panagiota, Lozano, Teresa, Bot, Christopher, Ellery, Jonathan, Whiteside, Sarah K., Imianowski, Charlotte J., Farrow, Stuart, Walker, Simon, Okkenhaug, Hanneke, Yang, Jie, Okkenhaug, Klaus, Kuo, Paula, and Roychoudhuri, Rahul
- Published
- 2020
- Full Text
- View/download PDF
7. Low human and murine Mcl-1 expression leads to a pro-apoptotic plaque phenotype enriched in giant-cells
- Author
-
Fontaine, Margaux A. C., Westra, Marijke M., Bot, Ilze, Jin, Han, Franssen, Aimée J. P. M., Bot, Martine, de Jager, Saskia C. A., Dzhagalov, Ivan, He, You-Wen, van Vlijmen, Bart J. M., Gijbels, Marion J. J., Reutelingsperger, Chris P., van Berkel, Theo J. C., Sluimer, Judith C., Temmerman, Lieve, and Biessen, Erik A. L.
- Published
- 2019
- Full Text
- View/download PDF
8. Induction of HLA-A2 restricted CD8 T cell responses against ApoB100 peptides does not affect atherosclerosis in a humanized mouse model
- Author
-
Schaftenaar, Frank H., Amersfoort, Jacob, Douna, Hidde, Kröner, Mara J., Foks, Amanda C., Bot, Ilze, Slütter, Bram A., van Puijvelde, Gijs H. M., Drijfhout, Jan W., and Kuiper, Johan
- Published
- 2019
- Full Text
- View/download PDF
9. Stress-induced mast cell activation contributes to atherosclerotic plaque destabilization
- Author
-
Lagraauw, H. Maxime, Wezel, Anouk, van der Velden, Daniël, Kuiper, Johan, and Bot, Ilze
- Published
- 2019
- Full Text
- View/download PDF
10. Blockade of the BLT1-LTB
- Author
-
Marie A C, Depuydt, Femke D, Vlaswinkel, Esmeralda, Hemme, Lucie, Delfos, Mireia N A Bernabé, Kleijn, Peter J, van Santbrink, Amanda C, Foks, Bram, Slütter, Johan, Kuiper, and Ilze, Bot
- Subjects
Mice ,Cell Movement ,Receptors, Leukotriene B4 ,Humans ,Animals ,Atherosclerosis ,Leukotriene B4 ,Plaque, Atherosclerotic - Abstract
Mast cells have been associated with the progression and destabilization of advanced atherosclerotic plaques. Reducing intraplaque mast cell accumulation upon atherosclerosis progression could be a potent therapeutic strategy to limit plaque destabilization. Leukotriene B
- Published
- 2022
11. Chronic use of inhaled corticosteroids in patients admitted for respiratory virus infections: a 6-year prospective multicenter study
- Author
-
Luque-Paz, David, Tattevin, Pierre, Loubet, Paul, Bénézit, François, Thibault, Vincent, Lainé, Fabrice, Vanhems, Philippe, Amour, Selilah, Lina, Bruno, Duval, Xavier, L’honneur, Anne-Sophie, Fidouh, Nadhira, Vallejo, Christine, Alain, Sophie, Galtier, Florence, Foulongne, Vincent, Lagathu, Gisèle, Lenzi, Nezha, Lesieur, Zineb, Launay, Odile, Jouneau, Stéphane, Loulergue, P., Momcilovic, S., Mira, J., Marin, N., Charpentier, J., Regent, A., Kanaan, R., Dumas, F., Doumenc, B., Lachatre, M., Szwebel, T., Kansao, J., Costa, Y., Alexandra, J., Becheur, H., Belghalem, K., Bernard, J., Bleibtreu, A., Boisseau, M., Bories, R., Brugiere, O., Brunet, F., Burdet, C., Casalino, E., Caseris, M., Chansiaux, C., Chauchard, M., Chavance, P., Choquet, C., Cloppet-Fontaine, A., Colosi, L., Couset, B., Crestani, B., Crocket, F., Debit, A., Delanoe, K, Descamps, V., Dieude, P., Dossier, A., Douron, N., Dupeyrat, E., Emeyrat, N., Fernet, C., Goulenok, T., Harent, S., Jouenne, R., Justet, A., Leleu, A., Lerat, I., Lilamand, M., Mal, H., Marceau, A., Metivier, A.-C., Oplelatora, K., Papo, T., Pelletier, A.-L., Pereira, L., Pradere, P., Prommier, R, Ralainnazava, P., Ranaivoision, M., Raynaud-Simon, A., Rioux, C., Sacre, K., Verry, V., Vuong, V., Yazdapanah, Y., Houhou, N., Géraud, P., Driss, V., Maugueret, V., Crantelle, L., Agostini, C., Ray, M., Letois, F., Mura, T., Serrand, C., Noslier, S., Giordano, A., Chevassus, H., Nyiramigisha, E., Merle, C., Bourdin, A., Konaté, A., Capdevilla, X., Du Cailar, G., Terminet, A., Blain, H., Leglise, M., Le Quellec, A., Corne, P., Landreau, L., Klouche, K., Bourgeois, A., Sebbane, M., Mourad, G., Leray, H., Postil, D., Alcolea, S., Couve-Deacon, E., Rogez, S., Argaud, L., Cour, M., Hernu, R., Simon, M., Baudry, T., Tazarourte, K., Bui-Xuan, C., Fattoum, J., Valette, M., Rochas, S., Cochennec, S., Thébault, E., Revest, M., Sébillotte, M., Le Bot, A., Baldeyrou, M., Patrat-Delon, S., Cailleaux, M., Pronier, C., CHU Pontchaillou [Rennes], ARN régulateurs bactériens et médecine (BRM), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Centre d'Investigation Clinique [Rennes] (CIC), Université de Rennes (UR)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Virulence Bactérienne et Infections Chroniques (VBIC), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), F-CRIN, Innovative clinical research network in vaccinology (I-REIVAC), Hospices Civils de Lyon (HCL), Centre International de Recherche en Infectiologie (CIRI), École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), CIC - CHU Bichat, Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), AP-HP - Hôpital Bichat - Claude Bernard [Paris], Centre d'Investigation Clinique de Limoges (CIC1435), CHU Limoges-Institut National de la Santé et de la Recherche Médicale (INSERM), Anti-infectieux : supports moléculaires des résistances et innovations thérapeutiques (RESINFIT), CHU Limoges-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST), Université de Limoges (UNILIM)-Université de Limoges (UNILIM), CIC Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital Saint Eloi (CHRU Montpellier), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), CIC Cochin Pasteur (CIC 1417), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôtel-Dieu-Groupe hospitalier Broca-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), and This work was not funded. The study sites received funding from Sanofi Pasteur and MSD for the FLUVAC study. Vaccine producers had no role in the study design, data analysis, decision to publish or preparation of the manuscript.
- Subjects
Adult ,Multidisciplinary ,[SDV]Life Sciences [q-bio] ,Respiratory Syncytial Virus Infections ,[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Adrenal Cortex Hormones ,Virus Diseases ,Respiratory Syncytial Virus, Human ,Influenza, Human ,Viruses ,Humans ,Prospective Studies ,Respiratory Tract Infections - Abstract
Inhaled corticosteroids (ICS) have been associated with increased risk of pneumonia. Their impact on respiratory virus infections is unclear. We performed a post-hoc analysis of the FLUVAC cohort, a multicenter prospective cohort study of adults hospitalized with influenza-like illness (ILI) during six consecutive influenza seasons (2012–2018). All patients were tested for respiratory virus infection by multiplex PCR on nasopharyngeal swabs and/or bronchoalveolar lavage. Risk factors were identified by logistic regression analysis. Among the 2658 patients included, 537 (20.2%) were treated with ICS before admission, of whom 282 (52.5%, 282/537) tested positive for at least one respiratory virus. Patients on ICS were more likely to test positive for non-influenza respiratory viruses (25.1% vs. 19.5%, P = 0.004), especially for adenovirus (aOR 2.36, 95% CI 1.18–4.58), and respiratory syncytial virus (aOR 2.08, 95% CI 1.39–3.09). Complications were reported in 55.9% of patients on ICS (300/537), primarily pneumonia (171/535, 32%). Among patients on chronic ICS who tested positive for respiratory virus, 14.2% (40/282) were admitted to intensive care unit, and in-hospital mortality rate was 2.8% (8/282). Chronic use of ICS is associated with an increased risk of adenovirus or RSV infections in patients admitted for ILI.
- Published
- 2021
- Full Text
- View/download PDF
12. Publisher Correction: High-temporal-resolution quasideterministic dynamics of granular stick-slip
- Author
-
Davy Dalmas, A. Le Bot, T. T. T. Nguyen, and T. Doanh
- Subjects
Multidisciplinary ,Science ,Dynamics (mechanics) ,Medicine ,High temporal resolution ,Slip (materials science) ,Mechanics ,Publisher Correction ,Geology - Abstract
We report high-temporal-resolution observations of the spontaneous instability of model granular materials under isotropic and triaxial compression in fully drained conditions during laboratory tests representative of earthquakes. Unlike in natural granular materials, in the model granular materials, during the first stage of the tests, i.e., isotropic compression, a series of local collapses of various amplitudes occurs under random triggering cell pressures. During the second stage, i.e., shearing under triaxial compression, the model granular samples exhibit very large quasiperiodic stick-slip motions at random deviatoric triggering stresses. These motions are responsible for very large stress drops that are described by power laws and are accurate over more than 3 decades in logarithmic space. Then, we identify the quasideterministic nature of these stick-slip events, assuming that they are fully controlled by the cell pressure and solid fraction. Finally, we discuss the potential mechanisms that could explain these intriguing behaviors and the possible links with natural earthquakes.
- Published
- 2021
13. Blockade of the BLT1-LTB4 axis does not affect mast cell migration towards advanced atherosclerotic lesions in LDLr−/− mice.
- Author
-
Depuydt, Marie A. C., Vlaswinkel, Femke D., Hemme, Esmeralda, Delfos, Lucie, Kleijn, Mireia N. A. Bernabé, van Santbrink, Peter J., Foks, Amanda C., Slütter, Bram, Kuiper, Johan, and Bot, Ilze
- Subjects
CELL migration ,WESTERN diet ,MYELOID cells ,ATHEROSCLEROTIC plaque ,MAST cells ,RNA sequencing ,INTERLEUKIN-9 ,AORTA - Abstract
Mast cells have been associated with the progression and destabilization of advanced atherosclerotic plaques. Reducing intraplaque mast cell accumulation upon atherosclerosis progression could be a potent therapeutic strategy to limit plaque destabilization. Leukotriene B
4 (LTB4 ) has been reported to induce mast cell chemotaxis in vitro. Here, we examined whether antagonism of the LTB4 -receptor BLT1 could inhibit mast cell accumulation in advanced atherosclerosis. Expression of genes involved in LTB4 biosynthesis was determined by single-cell RNA sequencing of human atherosclerotic plaques. Subsequently, Western-type diet fed LDLr−/− mice with pre-existing atherosclerosis were treated with the BLT1-antagonist CP105,696 or vehicle control three times per week by oral gavage. In the spleen, a significant reduction in CD11b+ myeloid cells was observed, including Ly6Clo and Ly6Chi monocytes as well as dendritic cells. However, atherosclerotic plaque size, collagen and macrophage content in the aortic root remained unaltered upon treatment. Finally, BLT1 antagonism did not affect mast cell numbers in the aortic root. Here, we show that human intraplaque leukocytes may be a source of locally produced LTB4 . However, BLT1-antagonism during atherosclerosis progression does not affect either local mast cell accumulation or plaque size, suggesting that other mechanisms participate in mast cell accumulation during atherosclerosis progression. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
14. Stress-induced mast cell activation contributes to atherosclerotic plaque destabilization
- Author
-
H. Maxime Lagraauw, Anouk Wezel, Ilze Bot, Johan Kuiper, and Daniël van der Velden
- Subjects
0301 basic medicine ,Apolipoprotein E ,Male ,medicine.medical_specialty ,Mice, Knockout, ApoE ,medicine.medical_treatment ,Immunology ,lcsh:Medicine ,Diet, High-Fat ,Article ,03 medical and health sciences ,Mice ,0302 clinical medicine ,In vivo ,Stress, Physiological ,Internal medicine ,medicine ,Immunology and Allergy ,Animals ,Mast Cells ,Acute stress ,lcsh:Science ,Multidisciplinary ,Chemistry ,business.industry ,Mast cell activation ,lcsh:R ,Stress induced ,Interleukin ,Plaque, Atherosclerotic ,Cell biology ,030104 developmental biology ,Cytokine ,Endocrinology ,Disease Progression ,lcsh:Q ,Restraint stress ,Cardiology and Cardiovascular Medicine ,business ,030217 neurology & neurosurgery - Abstract
Mast cells accumulate in the perivascular tissue during plaque progression and upon activation release pro-inflammatory cytokines and extracellular matrix degrading enzymes which fuel the inflammatory process and decrease lesion stability. Interestingly, mast cells have been shown to co-localize with peripheral neurons and contain receptors for various hormones and neuropeptides which are released upon exposure to stress. Therefore, we hypothesize that stress-induced neuronal activation of mast cells contributes to plaque destabilization. In apoE−/− mice the acute stress induced by 120′ restraint caused a significant increase in mast cell activation in the heart (37.3 ± 1.8% vs. 50.1 ± 4.9%). In parallel with a rise in serum corticosterone levels we observed a transient increase mast cell-specific β-hexosaminidase levels and the pro-inflammatory cytokine, interleukin-6 in the stressed mice compared to controls (55.9 ± 11.0 pg/ml vs. 29.6 ± 5.49 pg/ml). Subsequent characterization of atherosclerotic lesions in the aortic root revealed a significant reduction in lesion collagen content and a higher incidence of intraplaque hemorrhages, a hallmark of the vulnerable plaque (38.5% vs. 7.7%). Importantly, both these effects were reduced in mice treated with the mast cell stabilizer cromolyn and completely abolished in mast cell deficient (apoE−/−/Kit(W-sh/W-sh)) mice, thus strongly indicating the involvement of a mast cell-dependent response to stress in atherosclerotic plaque destabilization. We demonstrate that acute stress activates mast cells near atherosclerotic lesions and contributes to plaque destabilization, identifying acute stress as a risk factor for acute cardiovascular syndromes.
- Published
- 2018
15. Leukocyte Bim deficiency does not impact atherogenesis in ldlr
- Author
-
Lieve, Temmerman, Marijke M, Westra, Ilze, Bot, Bart J M, van Vlijmen, Niek, van Bree, Martine, Bot, Kim L L, Habets, Tom G H, Keulers, Johan, van der Vlag, Thomas G, Cotter, Theo J C, van Berkel, and Erik A L, Biessen
- Subjects
Inflammation ,Mice, Knockout ,Bcl-2-Like Protein 11 ,Immunoglobulins ,chemical and pharmacologic phenomena ,hemic and immune systems ,Apoptosis ,Hyperlipidemias ,Th1 Cells ,Atherosclerosis ,Article ,Autoimmune Diseases ,Immunity, Humoral ,Disease Models, Animal ,Mice ,Receptors, LDL ,Splenomegaly ,Leukocytes ,Animals ,Lymphocyte Count ,biological phenomena, cell phenomena, and immunity ,Bone Marrow Transplantation - Abstract
Proapoptotic Bcl-2 family member Bim is particularly relevant for deletion of autoreactive and activated T and B cells, implicating Bim in autoimmunity. As atherosclerosis is a chronic inflammatory process with features of autoimmune disease, we investigated the impact of hematopoietic Bim deficiency on plaque formation and parameters of plaque stability. Bim −/− or wild type bone marrow transplanted ldlr −/− mice were fed a Western type diet (WTD) for 5 or 10 weeks, after which they were immunophenotyped and atherosclerotic lesions were analyzed. Bim −/− transplanted mice displayed splenomegaly and overt lymphocytosis. CD4+ and CD8+ T cells were more activated (increased CD69 and CD71 expression, increased interferon gamma production). B cells were elevated by 147%, with a shift towards the pro-atherogenic IgG-producing B2 cell phenotype, resulting in a doubling of anti-oxLDL IgG1 antibody titers in serum of bim −/− mice. Bim −/− mice displayed massive intraplaque accumulation of Ig complexes and of lesional T cells, although this did not translate in changes in plaque size or stability features (apoptotic cell and macrophage content). The surprising lack in plaque phenotype despite the profound pro-atherogenic immune effects may be attributable to the sharp reduction of serum cholesterol levels in WTD fed bim −/− mice.
- Published
- 2016
16. Leukocyte Bim deficiency does not impact atherogenesis in ldlr −/− mice, despite a pronounced induction of autoimmune inflammation
- Author
-
Temmerman, Lieve, primary, Westra, Marijke M., additional, Bot, Ilze, additional, van Vlijmen, Bart J. M., additional, van Bree, Niek, additional, Bot, Martine, additional, Habets, Kim L. L., additional, Keulers, Tom G. H., additional, van der Vlag, Johan, additional, Cotter, Thomas G., additional, van Berkel, Theo J. C., additional, and Biessen, Erik A. L., additional
- Published
- 2017
- Full Text
- View/download PDF
17. MBD3 expression and DNA binding patterns are altered in a rat model of temporal lobe epilepsy
- Author
-
Joanna Bednarczyk, Katarzyna Lukasiuk, Konrad J. Dębski, and Anna Maria Bot
- Subjects
Male ,0301 basic medicine ,Immunoprecipitation ,Electric Stimulation Therapy ,Stimulation ,Status epilepticus ,Biology ,Epileptogenesis ,Article ,Rats, Sprague-Dawley ,03 medical and health sciences ,Epilepsy ,0302 clinical medicine ,medicine ,Animals ,Humans ,Neurons ,Multidisciplinary ,DNA ,Amygdala ,medicine.disease ,Molecular biology ,Mi-2/NuRD complex ,Rats ,DNA-Binding Proteins ,Disease Models, Animal ,Oligodendroglia ,030104 developmental biology ,Epilepsy, Temporal Lobe ,Gene Expression Regulation ,DNA methylation ,medicine.symptom ,Chromatin immunoprecipitation ,030217 neurology & neurosurgery ,Protein Binding - Abstract
The aim of the present study was to examine involvement of MBD3 (methyl-CpG-binding domain protein 3), a protein involved in reading DNA methylation patterns, in epileptogenesis and epilepsy. We used a well-characterized rat model of temporal lobe epilepsy that is triggered by status epilepticus, evoked by electrical stimulation of the amygdala. Stimulated and sham-operated animals were sacrificed 14 days after stimulation. We found that MBD3 transcript was present in neurons, oligodendrocytes and astrocytes in both control and epileptic animals. We detected the nuclear localization of MBD3 protein in neurons, mature oligodendrocytes and a subpopulation of astrocytes but not in microglia. Amygdala stimulation significantly increased the level of MBD3 immunofluorescence. Immunoprecipitation followed by mass spectrometry and Western blot revealed that MBD3 in the adult brain assembles the NuRD complex, which also contains MTA2, HDAC2 and GATAD2B. Using chromatin immunoprecipitation combined with deep sequencing, we observed differences in the occupancy of DNA regions by MBD3 protein between control and stimulated animals. This was not followed by subsequent changes in the mRNA expression levels of selected MBD3 targets. Our data demonstrate for the first time alterations in the MBD3 expression and DNA occupancy in the experimental model of epilepsy.
- Published
- 2016
- Full Text
- View/download PDF
18. Etiology matters – Genomic DNA Methylation Patterns in Three Rat Models of Acquired Epilepsy
- Author
-
Ishant Khurana, Mark Ziemann, Antony Kaspi, KN Harikrishnan, Anna Maria Bot, Asla Pitkänen, Katja Kobow, Assam El-Osta, Konrad J. Dębski, Katarzyna Lukasiuk, and Noora Puhakka
- Subjects
Male ,0301 basic medicine ,Gerontology ,Higher education ,Rat model ,Library science ,Article ,Rats sprague dawley ,Rats, Sprague-Dawley ,German ,03 medical and health sciences ,0302 clinical medicine ,Animals ,Cluster Analysis ,Medicine ,RNA, Messenger ,Epilepsy ,Genome ,Multidisciplinary ,business.industry ,Acquired epilepsy ,Molecular Sequence Annotation ,DNA Methylation ,language.human_language ,Disease Models, Animal ,genomic DNA ,030104 developmental biology ,Gene Expression Regulation ,Nerve Degeneration ,Etiology ,language ,Christian ministry ,business ,030217 neurology & neurosurgery - Abstract
This study tested the hypothesis that acquired epileptogenesis is accompanied by DNA methylation changes independent of etiology. We investigated DNA methylation and gene expression in the hippocampal CA3/dentate gyrus fields at 3 months following epileptogenic injury in three experimental models of epilepsy: focal amygdala stimulation, systemic pilocarpine injection, or lateral fluid-percussion induced traumatic brain injury (TBI) in rats. In the models studies, DNA methylation and gene expression profiles distinguished controls from injured animals. We observed consistent increased methylation in gene bodies and hypomethylation at non-genic regions. We did not find a common methylation signature in all three different models and few regions common to any two models. Our data provide evidence that genome-wide alteration of DNA methylation signatures is a general pathomechanism associated with epileptogenesis and epilepsy in experimental animal models, but the broad pathophysiological differences between models (i.e. pilocarpine, amygdala stimulation and post-TBI) are reflected in distinct etiology-dependent DNA methylation patterns.
- Published
- 2016
- Full Text
- View/download PDF
19. Uremia does not affect neointima formation in mice
- Author
-
Aarup, Annemarie, primary, Nielsen, Carsten H., additional, Bisgaard, Line S., additional, Bot, Ilze, additional, El-Ali, Henrik H., additional, Kjaer, Andreas, additional, Nielsen, Lars B., additional, and Pedersen, Tanja X., additional
- Published
- 2017
- Full Text
- View/download PDF
20. Mesenchymal Stem Cells Reduce Murine Atherosclerosis Development
- Author
-
Janine van Duijn, Saskia C. A. de Jager, Ilze Bot, Peter J. van Santbrink, Melissa van Pel, Johan Kuiper, and Vanessa Frodermann
- Subjects
ACUTE MYOCARDIAL-INFARCTION ,medicine.medical_specialty ,T cell ,RECEPTOR-DEFICIENT MICE ,Adipose tissue ,LIPOPROTEIN-LIPASE ,Inflammation ,Biology ,CCL2 ,Mesenchymal Stem Cell Transplantation ,DENSITY-LIPOPROTEIN ,T-Lymphocytes, Regulatory ,DENDRITIC CELLS ,Article ,Mice ,Internal medicine ,medicine ,Animals ,Humans ,Aorta ,IN-VIVO ,Mice, Knockout ,Lipoprotein lipase ,Multidisciplinary ,Macrophages ,Mesenchymal stem cell ,Mesenchymal Stem Cells ,Lipid metabolism ,MOUSE MODEL ,Atherosclerosis ,Diet ,Disease Models, Animal ,ADIPOSE-TISSUE ,Endocrinology ,medicine.anatomical_structure ,Receptors, LDL ,STROMAL CELLS ,Immunology ,medicine.symptom ,KNOCKOUT MICE ,Lipoprotein - Abstract
Mesenchymal stem cells (MSCs) have regenerative properties, but recently they were also found to have immunomodulatory capacities. We therefore investigated whether MSCs could reduce atherosclerosis, which is determined by dyslipidaemia and chronic inflammation. We adoptively transferred MSCs into low-density lipoprotein-receptor knockout mice and put these on a Western-type diet to induce atherosclerosis. Initially after treatment, we found higher levels of circulating regulatory T cells. In the long-term, overall numbers of effector T cells were reduced by MSC treatment. Moreover, MSC-treated mice displayed a significant 33% reduction in circulating monocytes and a 77% reduction of serum CCL2 levels. Most strikingly, we found a previously unappreciated effect on lipid metabolism. Serum cholesterol was reduced by 33%, due to reduced very low-density lipoprotein levels, likely a result of reduced de novo hepatic lipogenesis as determined by a reduced expression of Stearoyl-CoA desaturase-1 and lipoprotein lipase. MSCs significantly affected lesion development, which was reduced by 33% in the aortic root. These lesions contained 56% less macrophages and showed a 61% reduction in T cell numbers. We show here for the first time that MSC treatment affects not only inflammatory responses but also significantly reduces dyslipidaemia in mice. This makes MSCs a potent candidate for atherosclerosis therapies.
- Published
- 2015
- Full Text
- View/download PDF
21. A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy
- Author
-
Bot, Ilze, primary, Ortiz Zacarías, Natalia V., additional, de Witte, Wilhelmus E. A., additional, de Vries, Henk, additional, van Santbrink, Peter J., additional, van der Velden, Daniël, additional, Kröner, Mara J., additional, van der Berg, Dirk-Jan, additional, Stamos, Dean, additional, de Lange, Elizabeth C. M., additional, Kuiper, Johan, additional, IJzerman, Adriaan P., additional, and Heitman, Laura H., additional
- Published
- 2017
- Full Text
- View/download PDF
22. Leukocyte TLR5 deficiency inhibits atherosclerosis by reduced macrophage recruitment and defective T-cell responsiveness
- Author
-
Ellenbroek, Guilielmus H.J.M., primary, van Puijvelde, Gijs H.M., additional, Anas, Adam A., additional, Bot, Martine, additional, Asbach, Miriam, additional, Schoneveld, Arjan, additional, van Santbrink, Peter J., additional, Foks, Amanda C., additional, Timmers, Leo, additional, Doevendans, Pieter A., additional, Pasterkamp, Gerard, additional, Hoefer, Imo E., additional, van der Poll, Tom, additional, Kuiper, Johan, additional, and de Jager, Saskia C.A., additional
- Published
- 2017
- Full Text
- View/download PDF
23. Inhibition of lysophosphatidic acid receptors 1 and 3 attenuates atherosclerosis development in LDL-receptor deficient mice
- Author
-
Kritikou, Eva, primary, van Puijvelde, Gijs H. M., additional, van der Heijden, Thomas, additional, van Santbrink, Peter J., additional, Swart, Maarten, additional, Schaftenaar, Frank H., additional, Kröner, Mara J., additional, Kuiper, Johan, additional, and Bot, Ilze, additional
- Published
- 2016
- Full Text
- View/download PDF
24. MBD3 expression and DNA binding patterns are altered in a rat model of temporal lobe epilepsy
- Author
-
Bednarczyk, Joanna, primary, Dębski, Konrad J., additional, Bot, Anna M., additional, and Lukasiuk, Katarzyna, additional
- Published
- 2016
- Full Text
- View/download PDF
25. Etiology matters – Genomic DNA Methylation Patterns in Three Rat Models of Acquired Epilepsy
- Author
-
Dębski, Konrad J., primary, Pitkanen, Asla, additional, Puhakka, Noora, additional, Bot, Anna M., additional, Khurana, Ishant, additional, Harikrishnan, KN, additional, Ziemann, Mark, additional, Kaspi, Antony, additional, El-Osta, Assam, additional, Lukasiuk, Katarzyna, additional, and Kobow, Katja, additional
- Published
- 2016
- Full Text
- View/download PDF
26. Deficiency of the TLR4 analogue RP105 aggravates vein graft disease by inducing a pro-inflammatory response
- Author
-
Wezel, Anouk, primary, de Vries, Margreet R., additional, Maassen, Johanna M., additional, Kip, Peter, additional, Peters, Erna A., additional, Karper, Jacco C., additional, Kuiper, Johan, additional, Bot, Ilze, additional, and Quax, Paul H. A., additional
- Published
- 2016
- Full Text
- View/download PDF
27. Nitrogen and water availability to tomato plants triggers bottom-up effects on the leafminer Tuta absoluta
- Author
-
Edwige Amiens-Desneux, Peng Han, Jacques Le Bot, Anne Violette Lavoir, Nicolas Desneux, Institut Sophia Agrobiotech (ISA), Centre National de la Recherche Scientifique (CNRS)-Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Institut National de la Recherche Agronomique (INRA), Unité de recherche Plantes et Systèmes de Culture Horticoles (PSH), Institut National de la Recherche Agronomique (INRA), Environment and Agronomy department of INRA, and Chinese government
- Subjects
0106 biological sciences ,[SDV.SA]Life Sciences [q-bio]/Agricultural sciences ,Plant growth ,hauteur de la tige ,Nitrogen ,gestion de l'azote ,chemistry.chemical_element ,Moths ,disponibilité en eau ,010603 evolutionary biology ,01 natural sciences ,Article ,Nitrogen treatment ,Host-Parasite Interactions ,Lepidoptera genitalia ,Quantitative Trait, Heritable ,teneur en azote ,Animals ,2. Zero hunger ,interaction plante pathogène ,Multidisciplinary ,biology ,apport azoté ,fungi ,Water ,disponibilité en azote ,food and beverages ,Gelechiidae ,biology.organism_classification ,tuta absoluta ,Carbon ,Agricultural sciences ,Plant Leaves ,010602 entomology ,chemistry ,Agronomy ,solanum lycopersicum ,Chemical defense ,Tuta absoluta ,Solanum ,Sciences agricoles - Abstract
International audience; This study examined the effects of various levels of nitrogen inputs (optimal, insufficient and excessive) and water inputs (optimal, low drought and high drought) to tomato plants (Solanum lycopersicum) on survival and development of an invasive tomato leafminer, Tuta absoluta (Meytick) (Lepidoptera: Gelechiidae). Plant growth i.e. plant height and the number of nodes declined under insufficient or excessive nitrogen treatment. Compared to optimal N, insufficient N treatment decreased leaf N content and increased the carbon/nitrogen ratio (C/N) whereas an excess of N had no effect on both leaf N content and leaf C/N ratio. Sub-optimal nitrogen supplies, water treatments and their interactions, significantly reduced the leafminer survival rate and slowed down its development. Together with the findings from three recent companion studies, we assumed that a combination of changes in nutritional value and chemical defense could explain these observed effects. Furthermore, our findings supported both the ‘‘Plant vigor hypothesis’’ and the ‘‘Nitrogen limitation hypothesis’’
- Published
- 2014
- Full Text
- View/download PDF
28. Mesenchymal Stem Cells Reduce Murine Atherosclerosis Development
- Author
-
Frodermann, Vanessa, primary, van Duijn, Janine, additional, van Pel, Melissa, additional, van Santbrink, Peter J., additional, Bot, Ilze, additional, Kuiper, Johan, additional, and de Jager, Saskia C. A., additional
- Published
- 2015
- Full Text
- View/download PDF
29. Nitrogen and water availability to tomato plants triggers bottom-up effects on the leafminer Tuta absoluta
- Author
-
Han, Peng, primary, Lavoir, Anne-Violette, additional, Le Bot, Jacques, additional, Amiens-Desneux, Edwige, additional, and Desneux, Nicolas, additional
- Published
- 2014
- Full Text
- View/download PDF
30. Leukocyte Bim deficiency does not impact atherogenesis in ldlr −/− mice, despite a pronounced induction of autoimmune inflammation
- Author
-
Lieve Temmerman, Marijke M. Westra, Ilze Bot, Bart J. M. van Vlijmen, Niek van Bree, Martine Bot, Kim L. L. Habets, Tom G. H. Keulers, Johan van der Vlag, Thomas G. Cotter, Theo J. C. van Berkel, and Erik A. L. Biessen
- Subjects
Medicine ,Science - Abstract
Abstract Proapoptotic Bcl-2 family member Bim is particularly relevant for deletion of autoreactive and activated T and B cells, implicating Bim in autoimmunity. As atherosclerosis is a chronic inflammatory process with features of autoimmune disease, we investigated the impact of hematopoietic Bim deficiency on plaque formation and parameters of plaque stability. Bim −/− or wild type bone marrow transplanted ldlr −/− mice were fed a Western type diet (WTD) for 5 or 10 weeks, after which they were immunophenotyped and atherosclerotic lesions were analyzed. Bim −/− transplanted mice displayed splenomegaly and overt lymphocytosis. CD4+ and CD8+ T cells were more activated (increased CD69 and CD71 expression, increased interferon gamma production). B cells were elevated by 147%, with a shift towards the pro-atherogenic IgG-producing B2 cell phenotype, resulting in a doubling of anti-oxLDL IgG1 antibody titers in serum of bim −/− mice. Bim −/− mice displayed massive intraplaque accumulation of Ig complexes and of lesional T cells, although this did not translate in changes in plaque size or stability features (apoptotic cell and macrophage content). The surprising lack in plaque phenotype despite the profound pro-atherogenic immune effects may be attributable to the sharp reduction of serum cholesterol levels in WTD fed bim −/− mice.
- Published
- 2017
- Full Text
- View/download PDF
31. Uremia does not affect neointima formation in mice
- Author
-
Annemarie Aarup, Carsten H. Nielsen, Line S. Bisgaard, Ilze Bot, Henrik H. El-Ali, Andreas Kjaer, Lars B. Nielsen, and Tanja X. Pedersen
- Subjects
Medicine ,Science - Abstract
Abstract Atherosclerotic cardiovascular disease is a major complication of chronic kidney disease (CKD). CKD leads to uremia, which modulates the phenotype of aortic smooth muscle cells (SMCs). Phenotypic modulation of SMCs plays a key role in accelerating atherosclerosis. We investigated the hypothesis that uremia potentiates neointima formation in response to vascular injury in mice. Carotid wire injury was performed on C57BL/6 wt and apolipoprotein E knockout (Apoe −/−) mice two weeks after induction of uremia by 5/6 nephrectomy. Wire injury led to neointima formation and downregulation of genes encoding classical SMC markers (i.e., myocardin, α-smooth muscle actin, SM22-alpha, and smooth muscle myosin heavy chain) in both wt and Apoe −/− mice. Contrary to our expectations, uremia did not potentiate neointima formation, nor did it affect intimal lesion composition as judged from magnetic resonance imaging and histological analyses. Also, there was no effect of uremia on SMC marker gene expression in the injured carotid arteries, suggesting that there may be different effects of uremia on SMCs in different vascular beds. In conclusion, uremia does not accelerate neointima formation in response to wire injury of the carotid artery in mice.
- Published
- 2017
- Full Text
- View/download PDF
32. A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy
- Author
-
Ilze Bot, Natalia V. Ortiz Zacarías, Wilhelmus E. A. de Witte, Henk de Vries, Peter J. van Santbrink, Daniël van der Velden, Mara J. Kröner, Dirk-Jan van der Berg, Dean Stamos, Elizabeth C. M. de Lange, Johan Kuiper, Adriaan P. IJzerman, and Laura H. Heitman
- Subjects
Medicine ,Science - Abstract
Abstract CC Chemokine Receptor 2 (CCR2) and its endogenous ligand CCL2 are involved in a number of diseases, including atherosclerosis. Several CCR2 antagonists have been developed as potential therapeutic agents, however their in vivo clinical efficacy was limited. In this report, we aimed to determine whether 15a, an antagonist with a long residence time on the human CCR2, is effective in inhibiting the development of atherosclerosis in a mouse disease model. First, radioligand binding assays were performed to determine affinity and binding kinetics of 15a on murine CCR2. To assess the in vivo efficacy, western-type diet fed apoE−/− mice were treated daily with 15a or vehicle as control. Treatment with 15a reduced the amount of circulating CCR2+ monocytes and the size of the atherosclerotic plaques in both the carotid artery and the aortic root. We then showed that the long pharmacokinetic half-life of 15a combined with the high drug concentrations ensured prolonged CCR2 occupancy. These data render 15a a promising compound for drug development and confirms high receptor occupancy as a key parameter when targeting chemokine receptors.
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.